Petros pharmaceuticals to partner with renowned big data provider to enable rx-to-otc switch across multiple indications

Company to integrate industry leading big data technology solutions into its ai-driven platform to expand capabilities in identifying eligible patients to receive formerly rx medications over the counter new york, ny / access newswire / march 20, 2025 / petros pharmaceuticals, inc. (nasdaq:ptpi) ("petros" or the "company"), a company focused on expanding consumer access to medication through over-the-counter ("otc") drug development programs, today announces a collaboration with renowned big data and analytics leader to enhance the development of its proprietary technology solutions designed to facilitate rx-to-otc switches for pharmaceutical products. the collaboration will incorporate an automated credentialing solution to help improve the company's identity verification system, which also encompasses an ai component.
PTPI Ratings Summary
PTPI Quant Ranking